Company / Working Capital
Exelixis Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.0B
FY2025
5-year range
$923.7M / $1.5B
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#37 of 213
Health Care
What the data says
Exelixis's working capital of $1.0B is higher than 83% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $200M in FY2016 to $1.5B in FY2021.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of -3.5%. Top quartile in the Health Care sector.
Improved from $924M to $1.0B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 213This company $1.0B Sector average $934.6M
▼
+11.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, working capital decreased 2.5% year-over-year.
- Ranks #37 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -2.5% |
| FY2024 | $1.1B | +15.2% |
| FY2023 | $923.7M | -28.6% |
| FY2022 | $1.3B | -13.5% |
| FY2021 | $1.5B | +20.7% |
| FY2020 | $1.2B | +42.9% |
| FY2019 | $868.4M | +9.7% |
| FY2018 | $791.5M | +114.1% |
| FY2017 | $369.7M | +84.7% |
| FY2016 | $200.2M | +58.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026